Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.97NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.177.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CL.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAUNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XADNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XABNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XALNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBWNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-982.809US
AY.39.1.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.15 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used